A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs.
about
Immunity Elicited by an Experimental Vaccine Based on Recombinant Flagellin-Porcine Circovirus Type 2 Cap Fusion Protein in PigletsCurrent Status of Veterinary VaccinesEmerging and re-emerging swine virusesPorcine Circovirus Type 2 (PCV2) Vaccines in the Context of Current Molecular Epidemiology.Effects of porcine circovirus type 2 (PCV2) maternal antibodies on experimental infection of piglets with PCV2.Reduction of porcine circovirus type 2 (PCV2) viremia by a reformulated inactivated chimeric PCV1-2 vaccine-induced humoral and cellular immunity after experimental PCV2 challenge.Porcine circovirus type 2 associated disease: update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies.A live-attenuated chimeric porcine circovirus type 2 (PCV2) vaccine is transmitted to contact pigs but is not upregulated by concurrent infection with porcine parvovirus (PPV) and porcine reproductive and respiratory syndrome virus (PRRSV) and is efStudies on porcine circovirus type 2 vaccination of 5-day-old piglets.Rescue of a duck circovirus from an infectious DNA clone in ducklingsComparative efficacy of experimental inactivated and live-attenuated chimeric porcine circovirus (PCV) 1-2b vaccines derived from PCV1 and PCV2b isolates originated in China.Managing variability in decision making in swine growing-finishing unitsRescue of a porcine anellovirus (torque teno sus virus 2) from cloned genomic DNA in pigs.Analysis of putative ORF3 gene within porcine circovirus type 2.Postweaning multisystemic wasting syndrome (PMWS) in pigs with particular emphasis on the causative agent, the mode of transmission, the diagnostic tools and the control measures. A review.Recognition of the different structural forms of the capsid protein determines the outcome following infection with porcine circovirus type 2.Porcine circovirus diseases.Formulation and delivery of vaccines: Ongoing challenges for animal management.Identification and functional analysis of the novel ORF4 protein encoded by porcine circovirus type 2Comparative effects of vaccination against porcine circovirus type 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) in a PCV2-PRRSV challenge modelA live-attenuated and an inactivated chimeric porcine circovirus (PCV)1-2 vaccine are both effective at inducing a humoral immune response and reducing PCV2 viremia and intrauterine infection in female swine of breeding age.Comparative analysis of apoptotic changes in peripheral immune organs and lungs following experimental infection of piglets with highly pathogenic and classical porcine reproductive and respiratory syndrome virus.Two amino acid mutations in the capsid protein of type 2 porcine circovirus (PCV2) enhanced PCV2 replication in vitro and attenuated the virus in vivo.Epidemiology and horizontal transmission of porcine circovirus type 2 (PCV2).Best practice and future challenges for vaccination against porcine circovirus type 2.Serological profile of torque teno sus virus species 1 (TTSuV1) in pigs and antigenic relationships between two TTSuV1 genotypes (1a and 1b), between two species (TTSuV1 and -2), and between porcine and human anelloviruses.A candidate inactivated chimeric vaccine PCV1-2 constructed based on PCV1 and PCV2 isolates originating in China and its evaluation in conventional pigs in regard to protective efficacy against PCV2 infection.Replacement of the replication factors of porcine circovirus (PCV) type 2 with those of PCV type 1 greatly enhances viral replication in vitro.A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naïve pigs under experimental conditions.Inactivated chimeric porcine circovirus (PCV) 1-2 vaccines based on genotypes 2b and 2d exhibit similar immunological effectiveness in protecting pigs against challenge with PCV2b strain 0233.Enhancement of the immunogenicity of a porcine circovirus type 2 DNA vaccine by a recombinant plasmid coexpressing capsid protein and porcine interleukin-6 in mice.Immune responses of piglets immunized by a recombinant plasmid containing porcine circovirus type 2 and porcine interleukin-18 genes.Chimeric porcine circoviruses (PCV) containing amino acid epitope tags in the C terminus of the capsid gene are infectious and elicit both anti-epitope tag antibodies and anti-PCV type 2 neutralizing antibodies in pigs.Efficacy of single dose of an inactivated porcine circovirus type 2 (PCV2) whole-virus vaccine with oil adjuvant in piglets.Influence of maternal antibodies on efficacy of porcine circovirus type 2 (PCV2) vaccination to protect pigs from experimental infection with PCV2.Limited susceptibility of three different mouse (Mus musculus) lines to Porcine circovirus-2 infection and associated lesions.An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge modelBeak and feather disease virus infection in cockatiels (Nymphicus hollandicus).Profile of Xiang-Jin Meng.Experimental reproduction of postweaning multisystemic wasting syndrome in pigs by dual infection with Mycoplasma hyopneumoniae and porcine circovirus type 2.
P2860
Q27326717-592EADCE-A5C4-42C3-96F5-3E323188D77DQ27480923-308ABE71-8DAD-4492-BF01-E44FC32D3DF8Q28256924-0BB6D485-84E0-4B9B-950A-10591CCF2751Q30234530-897B6E1C-B0ED-476E-A842-EC707B38D46FQ34143517-6C3410BE-2A49-46C6-A458-82DD6A3F860FQ34451426-CA7423BE-9306-4A22-923A-0D400B85D117Q34712944-605A905D-29F0-4BBB-B603-63677584B87EQ35138806-48374DD8-EC57-44D8-B572-F271552DA56FQ35530199-55CF263D-346F-4B1F-99A1-CF76C07F44FDQ35669540-4C14EE3E-651E-4186-B5BA-1674B2FA1133Q35899051-FF3E45DB-27FE-4B89-9CB6-0A08F3A02D62Q36008820-91C957A9-1904-4200-A9A0-1E14AE898F04Q36023084-7C1B1072-2E5E-44FE-9A0A-68DF5ABD7B5FQ36066031-CA682668-7C40-49A5-BC27-C86D93408720Q36292040-AF6AD54B-A2B7-4283-A739-34D1F7E8DCF8Q36414373-163471C5-77DD-4F48-8194-B587E08CC33FQ36439016-935190F0-313C-4B68-9C75-A852120712D6Q36470265-C88BC712-01B6-4AD9-8F83-E1372D0BC0F5Q36559892-C1577BAB-6495-4370-9524-05406667AC66Q36668529-F54F5FA6-3D26-466B-8346-64CA9A448D6DQ37425276-C2CB0F8E-A4F5-44A8-B4E3-2FC5357BC377Q37479756-A6D277F9-E25A-4402-8400-BF6AC11C5B8CQ37682981-437D849C-E3B8-4F6F-AA7D-8446BC7CC9D8Q37810660-815C6C61-EC1C-4108-AFD4-2091F0F3F801Q38268599-44ACF9D8-3F5B-4B03-B97D-21C914BC14F7Q39312055-D64E41A3-28F7-441A-9975-01DD843F8F3EQ39606483-5445C56F-BB37-49EB-8DD4-1213BDB4A64FQ39688958-6751914D-DB17-412B-BE1A-AE953F579967Q40423071-CD97CB4B-0547-4A81-8338-D4579B9F8366Q40512056-D5137B81-6434-4E83-99EF-61946EE51739Q41494485-47852CE0-FD17-4289-BEAA-2140578A9B74Q41721496-D2FFA8D2-71CA-4B9A-9095-3A893377FCE5Q41975299-3058DD3C-C217-4D86-B46F-4CA2AC437458Q42007715-ADBD5FB7-CE2E-46F6-B627-60CC1539856FQ43077193-BC94BB8F-2E4A-462E-9AD4-3480E3F0465DQ43148759-CAFF7914-39CD-4A9B-934B-B3B3D60F72E6Q45362988-B96BE873-3CB0-4B52-8A64-0C2BE6C6D9F4Q45397725-63FF47A6-09AB-4834-A1BB-8D1E14E43375Q47288359-8C1C6991-7FA2-4389-A04A-F68DFD88AAAFQ47892314-D072A55F-063D-474C-B30F-D289EA322479
P2860
A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
A chimeric porcine circovirus ...... gainst PCV2 infection in pigs.
@ast
A chimeric porcine circovirus ...... gainst PCV2 infection in pigs.
@en
A chimeric porcine circovirus
@nl
type
label
A chimeric porcine circovirus ...... gainst PCV2 infection in pigs.
@ast
A chimeric porcine circovirus ...... gainst PCV2 infection in pigs.
@en
A chimeric porcine circovirus
@nl
prefLabel
A chimeric porcine circovirus ...... gainst PCV2 infection in pigs.
@ast
A chimeric porcine circovirus ...... gainst PCV2 infection in pigs.
@en
A chimeric porcine circovirus
@nl
P2093
P2860
P1433
P1476
A chimeric porcine circovirus ...... gainst PCV2 infection in pigs.
@en
P2093
P2860
P304
P356
10.1128/JVI.78.12.6297-6303.2004
P407
P577
2004-06-01T00:00:00Z